Central Ohio Poison Center, Nationwide Children's Hospital, Columbus, OH, USA.
College of Medicine, The Ohio State University, Columbus, OH, USA.
Clin Toxicol (Phila). 2020 Jul;58(7):676-687. doi: 10.1080/15563650.2019.1665182. Epub 2019 Oct 6.
To evaluate the substances used, outcomes, temporal and demographics associated with suicide attempts by self-poisoning in children and young adults aged 10-25 years old from 2000 to 2018. This is a retrospective review of suspected-suicide self-poisoning cases reported to the National Poison Data System (NPDS) from US Poison Centers from 2000 to 2018 for patients 10-25 years old. For comparison of annual rates, we obtained population data by year of age from the US Census Bureau. We evaluated changes in: monthly and annual incidence/rate per 100,000 population, substances used and outcome by patient age and demographics. There were 1,677,435 cases of suicide attempt by self-poisoning among individuals 10-25 years old reported to US PCCs from 2000 to 2018. There were 410,940 self-poisoning cases (24.5%) with a serious medical outcome, and the proportion of exposures that resulted in a serious medical outcome increased with increasing age group. For the age groups of 10-12, 13-15 and 16-18 years of age, there was a significant increase after 2011, which was influenced primarily by females. The substance groups with the greatest number of serious medical outcomes were OTC analgesics, antidepressants, antihistamines and antipsychotics. ADHD medications were common in the younger age groups of 10-15 years, while the sedative/hypnotics occurred more commonly in the older age groups. The groups with the greatest increase in serious medical outcomes after 2011 were antidepressants, OTC analgesics, antihistamines and ADHD medications. Opiates were less commonly involved (7.4%) in cases with serious medical outcomes and decreased significantly in the 19-25 year-old age groups after 2012. States with a lower population per square mile had a greater number of reported cases with serious medical outcomes. There was a significant decrease in the number of cases in the age groups of 10-18 years during the traditional non-school months of June-August compared with September-May. This seasonal trend occurred among cases with all outcomes and among cases with serious medical outcomes. This decrease did not occur in the age group of 19-21 years, and there was an increase during summer months in the age group 22-25 years. The substances used during self-poisoning varies by age group but appears to include substances available to that age group, with a significant increase after 2011, increased rates in more rural states, and a seasonal variation of increased rates during school months among adolescents but not among young adults. Two of the top substances, OTC analgesics and antihistamines, in all age groups, comprising more than a third of all substances used, are widely available over-the-counter with no restrictions regarding access. Of additional concern, ADHD medications had the highest risk of a serious medical outcome.
评估 2000 年至 2018 年间 10-25 岁儿童和青少年因自我中毒企图自杀的使用物质、结局、时间和人口统计学特征。这是对美国中毒中心国家毒物数据系统(NPDS)报告的疑似自杀性自我中毒病例进行的回顾性研究,患者年龄为 10-25 岁。为了比较年度率,我们从美国人口普查局获得了按年龄划分的人口数据。我们评估了以下方面的变化:每月和每年每 10 万人的发病率/率、按患者年龄和人口统计学特征使用的物质和结局。2000 年至 2018 年期间,有 1677435 例 10-25 岁个体因自我中毒企图自杀向美国 PCC 报告。有 410940 例(24.5%)自我中毒病例有严重医疗后果,随着年龄组的增加,导致严重医疗后果的暴露比例增加。对于 10-12、13-15 和 16-18 岁年龄组,自 2011 年以来显著增加,这主要受女性影响。有严重医疗后果的物质组中,非处方止痛药、抗抑郁药、抗组胺药和抗精神病药数量最多。ADHD 药物在 10-15 岁年龄组更为常见,而镇静/催眠药在年龄较大的年龄组更为常见。2011 年后,严重医疗后果的物质组中,抗抑郁药、非处方止痛药、抗组胺药和 ADHD 药物的数量显著增加。阿片类药物(7.4%)在有严重医疗后果的病例中较少涉及,并且在 2012 年后 19-25 岁年龄组中显著减少。每平方英里人口较少的州报告的严重医疗后果病例较多。与 9 月至 5 月相比,10-18 岁年龄组在传统非学校月份(6-8 月)的病例数量显著减少。这种季节性趋势发生在所有结局和严重医疗后果的病例中。在 19-21 岁年龄组中没有发生这种情况,而在 22-25 岁年龄组中,夏季月份的病例数量增加。自我中毒期间使用的物质按年龄组而有所不同,但似乎包括该年龄组可获得的物质,自 2011 年以来显著增加,在人口较少的州中发生率增加,以及青少年在学校期间的季节性增加,但在年轻成年人中没有增加。所有年龄组中排名前两位的物质(非处方止痛药和抗组胺药),占所有使用物质的三分之一以上,在没有限制获取途径的情况下广泛可通过柜台购买。更值得关注的是,ADHD 药物的严重医疗后果风险最高。